The Alliance Advancement Series
Presented on: Thursday, September 24, 2020
Use of marijuana and the varied forms of cannabis is steadily on the rise in the US as more states move to legalize the substance for both medicinal and recreational purposes. Transplant programs across the country also have a varied approach regarding pre and post-transplant use, as clear guidelines are lacking. Research into the effects of THC has been limited by its illegality at the federal level. Drug interactions warrant further evaluation and study. This review offers insight into the pre and post-transplant approach to marijuana and CBD oil use, drug interactions, and a review of proposed potential guidelines.
At the end of the webinar, participants should be able to:
- Describe the current use of marijuana, CBD, and THC derivatives, their effects, and potential risks and benefits.
- Identify mechanism of action and potential drug interactions.
- Outline potential guidelines for use of marijuana and CBD oil in the pre and post-transplant population.
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.